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-PI into the gastrointestinal tract. A chronic loss of cα 1 -PI may theoretically deplete serum cα 1 -PI, potentially altering the proteinase-to-proteinase inhibitor balance. Protein-losing enteropathy has been reported to occur frequently in certain dog breeds such as Yorkshire Terriers and to be associated with hypocobalaminemia. The objective was to compare serum cα 1 -PI concentrations in Yorkshire Terriers with and without cobalamin (COB) deficiency. Serum samples from 52 COB-deficient and 69 normocobalaminemic Yorkshire Terriers, which had been submitted to the Gastrointestinal Laboratory (2008-2011; College Station, TX), were included retrospectively. Serum cα 1 -PI concentrations were measured using an in-house radioimmunoassay and compared between Yorkshire Terriers with and without COB deficiency using a Mann-Whitney U test. A Fisher exact test was used to evaluate whether a decreased serum cα 1 -PI concentration is associated with COB deficiency in Yorkshire Terriers. Serum cα 1 -PI concentrations were significantly lower in COB-deficient Yorkshire Terriers (median: 1,016 mg/l, range: 315-3,945 mg/l) than in normocobalaminemic Yorkshire Terriers (median: 1,665 mg/l, range: 900-2,970 mg/l; P < 0.0001). One-fourth (n = 13) of the COB-deficient Yorkshire Terriers had a serum cα 1 -PI concentration below the lower limit of the reference interval (<732 mg/l), and COB deficiency was associated with decreased serum cα 1 -PI concentrations (P < 0.0001). In the current study, serum cα 1 -PI concentrations are significantly lower in COB-deficient Yorkshire Terriers when compared to normocobalaminemic Yorkshire Terriers. Further studies are needed to determine the functional and potential prognostic implications of serum cα 1 -PI concentrations in dogs with gastrointestinal disease.
The exact pathogenesis of PLE in the Yorkshire Terrier is unknown.
The histologic features in biopsies from dogs with IBD and/or intestinal lymphangiectasia can vary between duodenal and ileal samples. 3, 5 In some dogs, intestinal lymphangiectasia can only be seen in the ileum. 5 Cobalamin (COB) absorption occurs exclusively in the ileum of dogs. Hypocobalaminemia and hypoalbuminemia can occur concurrently, and both have been shown to be associated with chronic GI diseases (e.g., PLE and IBD) in dogs. 1 However, to the authors' knowledge, serum albumin and fecal and/or serum canine alpha 1 -proteinase inhibitor (cα 1 -PI) 9, 10 have not yet been reported in COB-deficient dogs of breeds frequently diagnosed with PLE (e.g., Yorkshire Terriers).
Measurement of serum albumin and fecal cα 1 -PI concentrations have been recommended for the diagnosis of dogs with suspected PLE, 5, 20 as PLE is associated with increased loss of cα 1 -PI into the GI tract and fecal cα 1 -PI concentrations have been shown to be increased in dogs with PLE. 19 Theoretically, chronic loss of cα 1 -PI may deplete serum cα 1 -PI, potentially altering the proteinase-to-proteinase inhibitor balance. 10, 23 Furthermore, serum cα 1 -PI concentrations are regulated within a narrow concentration range in healthy dogs 10 
Materials and methods

Sample population
Database information on canine serum samples from Yorkshire Terriers, submitted to the Gastrointestinal Laboratory (GI Lab) at Texas A&M University (College Station, TX) between December 1, 2008, and December 1, 2011, was retrospectively reviewed. Canine serum samples were generally submitted by primary care veterinarians to the GI Lab for evaluation of GI function.
Yorkshire Terriers
Serum samples from 121 Yorkshire Terriers were included. Serum COB concentrations (reference interval [RI]: 251-908 ng/l) a had been measured using an automated chemiluminescence assay. b Serum cα 1 -PI concentrations (RI: 732-1,802 mg/l) were measured using an in-house radioimmunoassay. 10 Concentrations of serum albumin (RI: 2.4-4.5 g/dl) and serum creatinine (RI: 0.5-1.4 mg/dl) were measured using a chemistry analyzer. c Because the canine serum samples had been submitted to the GI Lab for evaluation of GI function, results of routinely conducted serum tests to assess GI health, such as folate measured by an automated chemiluminescence assay (RI: 7.7-24.4 μg/l), d canine trypsin-like immunoreactivity (cTLI) using a commercially available radioimmunoassay (RI: 5.7-45.2 μg/l), d and canine pancreatic lipase immunoreactivity (cPLI) using the specific pancreatic lipase immunoassay (RI: 0-200 μg/l), d were also available.
For additional information about the clinical signs of the dogs at the time of sample submission, a standard questionnaire was sent to the primary care veterinarians. However, because the serum samples from some Yorkshire Terriers had been submitted via a reference laboratory, it was not possible to obtain additional information for all Yorkshire Terriers. Questionnaires for 15 (28.8%) COB-deficient and 24 (34.8%) normocobalaminemic Yorkshire Terriers were completed and returned by primary care veterinarians.
Cobalamin-deficient dogs of 6 other breeds
In addition, serum samples from 253 dogs (GSD, Labrador Retriever [Labrador], Shar-Pei, Boxer, Cocker Spaniel, and Beagle; Table 1 ) with undetectable serum COB concentrations from a previous study evaluating COB deficiency in Shar-Peis and dogs of 6 other breeds 8 were used to compare serum cα 1 -PI concentrations in COB-deficient Yorkshire Terriers and COB-deficient dogs of 6 other breeds. Also, serum albumin concentrations were measured using a chemistry analyzer c (as described above) to compare and correlate serum cα 1 -PI concentrations in COB-deficient Yorkshire Terriers and COB-deficient dogs of 6 other breeds. Serum samples from only those dogs were included where a sufficient amount of serum was available to measure serum concentrations of cα 1 -PI and albumin.
Statistical analyses
A commercially available software package e was used to perform all statistical analyses. A Mann-Whitney U test was used to compare age, serum cα 1 -PI concentrations, serum albumin and creatinine concentrations, GI function tests (i.e., serum folate, cTLI, and cPLI concentrations), and body condition score between COB-deficient Yorkshire Terriers and normocobalaminemic Yorkshire Terriers. A Fisher exact test was used to evaluate whether COB deficiency in Yorkshire Terriers is associated with decreased serum cα 1 -PI concentrations and decreased serum albumin concentrations. A Kruskal-Wallis test with a Dunn posttest was used to compare serum cα 1 -PI and serum albumin concentrations in COB-deficient Yorkshire Terriers and COB-deficient dogs of 6 other breeds. A Spearman rank sum correlation coefficient (ρ) was used to test the relationship between serum cα 1 -PI and serum albumin concentrations in COB-deficient Yorkshire Terriers and COB-deficient dogs of 6 other breeds. For all tests significance was set at P < 0.05.
A Fisher exact test was performed to determine whether the clinical signs are associated with COB deficiency in Yorkshire Terriers. Also, the odds ratio (OR) and the 95% confidence interval (CI) were calculated for these parameters. The cutoff for statistical significance was adjusted according to the number of clinical signs evaluated (n = 8) from P < 0.05 to P < 0.006, using a Bonferroni correction for multiple statistical comparisons. f
Results
Yorkshire Terriers
Fifty-two Yorkshire Terriers with an undetectable serum COB concentration (<150 ng/l) and 69 normocobalaminemic Yorkshire Terriers (median serum COB concentration: 615 ng/l, range: 394-906 ng/l) were identified; gender and age of the dogs from which the samples had been collected were recorded ( Table 1) . COB-deficient Yorkshire Terriers were significantly older (median: 8.0 years, range: 2.0-14.0 years) than normocobalaminemic Yorkshire Terriers (median: 7.0 years, range: 1.0-15.0 years; P = 0.0329; Table 1 ). Genderspecific differences were not identified between the 2 groups of Yorkshire Terriers (P > 0.05; Table 1 ).
Serum cα 1 -PI concentrations were significantly lower in COB-deficient Yorkshire Terriers than in normocobalaminemic Yorkshire Terriers (P < 0.0001; Fig. 1 ). One-fourth (n = 13) of the COB-deficient Yorkshire Terriers had serum cα 1 -PI concentrations below the lower limit of the RI (i.e., <732 mg/l), and COB deficiency was associated with a decreased serum cα 1 -PI concentration (OR: 47.5, 95% CI: 2.7-821.5; P < 0.0001; Fig. 2 ).
Serum concentrations of albumin were also significantly lower in COB-deficient Yorkshire Terriers than in normocobalaminemic Yorkshire Terriers (P < 0.0001; Fig. 1 ). Approximately 71% (n = 37) of the COB-deficient Yorkshire Terriers had serum albumin concentrations below the lower limit of the RI (<2.4 g/dl), and COB deficiency was associated with a decreased serum albumin concentration (OR: 25.9, 95% CI: 9.2-72.6; P < 0.0001; Fig. 2 ). All COBdeficient Yorkshire Terriers with a serum cα 1 -PI concentration <732 mg/l were also hypoalbuminemic.
Concentrations of serum creatinine were statistically significantly lower in COB-deficient Yorkshire Terriers (median: 0.6 mg/dl, range: 0.3-2.8 mg/dl) compared to normocobalaminemic Yorkshire Terriers (median: 0.8 mg/dl, range: 0.1-2.3 mg/dl; P = 0.0078). However, this difference was not considered clinically relevant because the median serum creatinine concentrations were within the RI for both groups of Yorkshire Terriers.
Serum folate concentrations were lower in COB-deficient Yorkshire Terriers (n = 52, median: 7.1 μg/l, range: 1.4-34.3 μg/l) than in normocobalaminemic Yorkshire Terriers (n = 69, median: 11.8 μg/l, range: 6.2-22.2 μg/l; P < 0.0001). No significant difference was found in serum cTLI concentrations between the 2 groups of Yorkshire Terriers (COBdeficient group: n = 47, median: 14.0 μg/l, range: 0.7-39.0 μg/l; and normocobalaminemic group: n = 67, median: 11.5 μg/l, range: 5.7-34.3 μg/l; P = 0.0534). Serum concentrations of cPLI were higher in COB-deficient Yorkshire Terriers (n = 43, median: 121 μg/l, range: 29-640 μg/l) than in normocobalaminemic Yorkshire Terriers (n = 68, median: 45 μg/l, range: 29-797 μg/l; P < 0.0001).
Information from the retrospective questionnaires revealed no differences in most clinical signs such as diarrhea, vomiting, weight loss, anorexia, respiratory signs, and abdominal distension between the 2 groups of Yorkshire Terriers (all P > 0.05; Table 2 ). COB-deficient Yorkshire Terriers were more commonly lethargic (n = 4, 27%) than normocobalaminemic Yorkshire Terriers (none, 0.0%; P = 0.0166; Table 3 ), but this difference was no longer significant after the Bonferroni correction. The body condition score (scale 1-5) was lower in COB-deficient Yorkshire Terriers (median: 2, range: 1-4, n = 15) than in normocobalaminemic Yorkshire Terriers (median: 3, range: 1-5, n = 20; P = 0.1310), but this difference did not reach statistical significance.
Cobalamin-deficient dogs of 6 other breeds
Serum cα 1 -PI concentrations differed among the 7 breeds of COB-deficient dogs (P < 0.0001; Fig. 3 ). The posttest revealed that COB-deficient Yorkshire Terriers had lower serum cα 1 -PI concentrations than COB-deficient GSDs, Labradors, and Shar-Peis (for all: P < 0.01), and COBdeficient Cocker Spaniels had lower serum cα 1 -PI concentrations than COB-deficient Labradors (P < 0.01).
Similarly, serum concentrations of albumin differed among the 7 breeds of COB-deficient dogs (P < 0.0001; Fig. 3 ). The posttest showed that COB-deficient Yorkshire Terriers had lower serum albumin concentrations than GSDs, Labradors, and Shar-Peis (for all: P < 0.01) with an undetectable serum COB concentration, and COB-deficient Cocker Spaniels had serum albumin concentrations lower than COBdeficient Labradors (P < 0.05).
A strong correlation was observed between serum cα 1 -PI concentrations and serum albumin concentrations in COBdeficient Yorkshire Terriers and COB-deficient Cocker Spaniels (for both: Spearman correlation coefficient ρ ≥ 0.78; P < 0.0001; Table 2 ; Fig. 4 ). Along these lines, a moderate to weak correlation between these 2 serum proteins was observed for normocobalaminemic Yorkshire Terriers, COB-deficient GSDs, COB-deficient Labradors, and COBdeficient Shar-Peis (0.30 ≤ ρ ≤ 0.61; P < 0.01; Table 3 ; Fig.  4 ). In contrast, no correlation between serum cα 1 -PI and albumin was found in COB-deficient Boxers and COBdeficient Beagles (for both: P > 0.05; Table 3 ; Fig. 4 ).
Discussion
In the current retrospective study, serum concentrations of cα 1 -PI were compared between COB-deficient and normocobalaminemic Yorkshire Terriers to evaluate the functional and potential prognostic implications of serum cα 1 -PI concentrations. It was found that COB-deficient Yorkshire Terriers were older than normocobalaminemic Yorkshire Terriers, while gender-specific differences were not observed. This may suggest that the disease process associated with COB deficiency in Yorkshire Terriers occurs in middle-aged to older dogs.
In the present study, it was observed that COB-deficient Yorkshire Terriers had lower serum cα 1 -PI and albumin concentrations than normocobalaminemic Yorkshire Terriers. Also, serum cα 1 -PI and serum albumin concentrations measured below the respective lower limit of the RI in approximately 25% and 71% of COB-deficient Yorkshire Terriers as opposed to 0% and approximately 9% of normocobalaminemic Yorkshire Terriers, respectively. The data revealed that COB deficiency in Yorkshire Terriers was associated with decreased serum cα 1 -PI and decreased serum albumin concentrations.
It has been stated that healthy dogs have a relatively narrow range of serum cα 1 -PI concentrations, and moderate changes (± 510.9 mg/l) in serum cα 1 -PI would be needed to be clinically significant. 10 In the current study, the difference in the median serum cα 1 -PI concentrations between COBdeficient and normocobalaminemic Yorkshire Terriers was greater than this value of 510.9 mg/l, 10 suggesting that the decrease in serum cα 1 -PI concentrations in Yorkshire Terriers with COB deficiency is clinically relevant.
COB (vitamin B 12 ) deficiency in Yorkshire Terriers was associated with decreased serum cα 1 -PI concentrations in the present study. Diseases, such as chronic liver 22 or exocrine pancreatic diseases, 21, 26 could affect serum cα 1 -PI concentrations. For instance, the liver is the main site for synthesis of cα 1 -PI and is also the main storage site for COB, which could explain a massive depletion of COB from the liver together with a decreased synthesis of cα 1 -PI in patients with chronic hepatic disease. It would have been ideal to measure additional serum parameters (e.g., hepatic enzyme activities and the concentration of pre-and postprandial bile acids) to evaluate hepatic function, especially because COB-deficient Yorkshire Terriers were older than normocobalaminemic Yorkshire Terriers in the study and changes in hepatic structure and function may occur in older dogs. 11 Also, the increased cPLI, and numerically higher cTLI concentrations in COB-deficient Yorkshire Terriers could indicate that pancreatic disorders are associated with decreased serum cα 1 -PI concentrations, as shown in human patients with chronic pancreatic disease. 21, 26 Along these lines, pancreatic dysfunction has also been described in dogs with PLE, 13 but serum cα 1 -PI concentrations were significantly higher in a small number of patients (n = 24) diagnosed with pancreatitis when compared to healthy controls (unpublished data, R. M. Heilmann, 2012) . Thus, further studies are needed to evaluate serum cα 1 -PI concentrations in dogs with exocrine pancreatic or hepatic disease.
The association between hypoalbuminemia and hypocobalaminemia is consistent with the results of studies in dogs with chronic enteropathies (e.g., IBD and PLE). 1 Fecal cα 1 -PI concentrations have been reported to be increased in dogs with PLE 19 ; however, serum cα 1 -PI concentrations in dogs with PLE and other GI diseases have not been evaluated extensively. The current breed-specific evaluation of serum cα 1 -PI concentrations showed that all COB-deficient -PI concentrations below the lower limit of the reference interval (<732 mg/l) were more frequently observed in COB-deficient Yorkshire Terriers (25.0%) than in normocobalaminemic (normal COB) Yorkshire Terriers (0.0%; P < 0.0001). B, hypoalbuminemia (<2.4 g/dl) was more frequently detected in COB-deficient Yorkshire Terriers (71.2%) than in normal COB Yorkshire Terriers (8.7%; P < 0.0001).
Yorkshire Terriers with a serum cα 1 -PI concentration below the lower limit of the RI were also hypoalbuminemic. However, ruling out renal protein loss as a cause of hypoalbuminemia 4 was a limitation due to the retrospective nature of the study. Measurement of the urine protein-to-creatinine ratio would be necessary to definitively rule out protein loss due to renal disease, such as chronic kidney disease. All COB-deficient Yorkshire Terriers in the present study had serum creatinine concentrations within the RI. However, with serum being the only sample type available due to the retrospective nature of the study, only serum creatinine was able to be used to rule out advanced chronic kidney disease, which does not rule out renal protein loss. Further research is warranted to evaluate serum cα 1 -PI concentrations in dogs with a normal urine protein-to-creatinine ratio.
In some cases of intestinal lymphangiectasia, endoscopic and/or histologic changes can be found in the ileum but not the duodenum. 3, 5 The results of the current study showed that approximately half of the hypocobalaminemic Yorkshire Terriers with decreased serum cα 1 -PI concentrations also had a decreased serum folate concentration, which would be consistent with the assumption that intestinal lymphangiectasia can affect the small intestine diffusely or be localized to the ileum alone. Further investigations to evaluate whether endoscopic and/or histologic GI lesions in Yorkshire Terriers with COB deficiency are associated with a decreased serum cα 1 -PI concentration are warranted. Because left-over serum samples were used for the current study, the clinical history and disease status remains unknown for many Yorkshire Terriers included in the study. However, a short questionnaire provided information about the disease status of a few Yorkshire Terriers with and without COB deficiency. Information obtained from the questionnaires revealed no differences between the 2 groups of Yorkshire Terriers regarding the presence of diarrhea, vomiting, weight loss, anorexia, respiratory signs, and abdominal distension. The body condition scores were lower in COBdeficient Yorkshire Terriers than in normocobalaminemic Yorkshire Terriers, although the difference did not reach statistical significance. However, using a 1-9 point scale instead of a 1-5 scale for the body condition score may have yielded a different result. Also, lethargy was the only clinical sign seen more frequently in COB-deficient Yorkshire Terriers but, after Bonferroni correction, this difference no longer reached statistical significance. COB deficiency has been shown to be prevalent in some dog breeds predisposed to the development of specific GI diseases (e.g., Shar-Peis, Labradors, GSDs) but not in Beagles, Boxers, Cocker Spaniels, and Yorkshire Terriers. 7 Interestingly, COB-deficient Yorkshire Terriers had lower serum cα 1 -PI and albumin concentrations than COB-deficient GSDs, Labradors, and Shar-Peis. In contrast, serum cα 1 -PI and albumin concentrations did not differ between COBdeficient Yorkshire Terriers and COB-deficient Cocker Spaniels, Boxers, and Beagles (breeds that have not been previously reported as being predisposed to GI disease such as PLE). This separation based on clinicopathologic parameters may suggest that different disease mechanisms are involved in the pathogenesis of COB deficiency and/or GI disease in these breeds and may aid in further characterizing these conditions. Breed-specific differences were observed for the relationship between serum cα 1 -PI and albumin. A strong correlation (as found in COB-deficient Yorkshire Terriers and Cocker Spaniels) would suggest that both cα 1 -PI and albumin are expressed and lost at the same rate. A weaker correlation between both protein concentrations in serum (seen in COBdeficient GSDs, Labradors, and Shar-Peis as well as in normocobalaminemic Yorkshire Terriers) or a lack of correlation (found in COB-deficient Boxers and Beagles) could be explained by differences in either their biosynthesis (e.g., inflammatory cells in the GI tract as a source of cα 1 -PI) or their different function (e.g., increased turnover of cα 1 -PI acting as a proteinase inhibitor in disease states or conditions with an increased release of proteinases). Again, these differences support the theory that breed-specific conditions can lead to COB deficiency and/or GI disease.
In conclusion, the current study found that COB-deficient Yorkshire Terriers had lower serum cα 1 -PI and albumin concentrations than normocobalaminemic Yorkshire Terriers, Table 3 ). and decreased serum cα 1 -PI and serum albumin concentrations were associated with COB deficiency in Yorkshire Terriers. The findings of this study provide an important additional parameter for the characterization of GI disease in Yorkshire Terriers. Further studies are needed to determine whether the COB status in these dogs is always associated with PLE and to determine the functional and potential prognostic implications of serum cα 1 -PI concentrations in dogs with GI disease (e.g., PLE and IBD).
